Abstract: The goal of this paper is to present the diagnostic
contribution that the screening instrument, Mini-Mental State
Examination-2: Expanded Version (MMSE-2:EV), brings in
detecting the cognitive impairment or in monitoring the progress of
degenerative disorders. The diagnostic signification is underlined by
the interpretation of the MMSE-2:EV scores, resulted from the test
application to patients with mild and major neurocognitive disorders.
The cases were selected from current practice, in order to cover vast
and significant neurocognitive pathology: mild cognitive impairment,
Alzheimer’s disease, vascular dementia, mixed dementia, Parkinson’s
disease, conversion of the mild cognitive impairment into
Alzheimer’s disease. The MMSE-2:EV version was used: it was
applied one month after the initial assessment, three months after the
first reevaluation and then every six months, alternating the blue and
red forms. Correlated with age and educational level, the raw scores
were converted in T scores and then, with the mean and the standard
deviation, the z scores were calculated. The differences of raw scores
between the evaluations were analyzed from the point of view of
statistic signification, in order to establish the progression in time of
the disease. The results indicated that the psycho-diagnostic approach
for the evaluation of the cognitive impairment with MMSE-2:EV is
safe and the application interval is optimal. In clinical settings with a
large flux of patients, the application of the MMSE-2:EV is a safe
and fast psychodiagnostic solution. The clinicians can draw objective
decisions and for the patients: it does not take too much time and
energy, it does not bother them and it doesn’t force them to travel
frequently.
Abstract: For the last decade, statistics show traumatic brain
injury (TBI) is a growing concern in our legal system. In an effort to
obtain data regarding the influence of neuropsychological expert
witness testimony in a criminal case, this study tested three
hypotheses. H1: The majority of jurors will vote not guilty, due to
mild head injury. H2: The jurors will give more credence to the
testimony of the neuropsychologist rather than the psychiatrist. H3:
The jurors will be more lenient in their sentencing, given the
testimony of the neuropsychologist-s testimony. The criterion for
inclusion in the study as a participant is identical to those used for
inclusion in the eligibility for jury duty in the United States. A chisquared
test was performed to analyze the data for the three
hypotheses. The results supported all of the hypotheses; however
statistical significance was seen in H1 and H2 only.